The CVProfilor^® MD-3000 System is CE Marked and is designed exclusively for use in physicians’ offices outside the United States to non-invasively assess the health of patients’ large and small arteries for the early detection and management of vascular disease. The CVProfilor^® MD-3000 System improves patient care by allowing physicians’ to detect a premature loss of arterial elasticity in the microvasculature, by providing new clinical information on the cardiovascular health of patients, by expanding vascular disease assessment to include teens and young adults, by monitoring the effects that cardiovascular drugs have on vascular elasticity, and by establishing a baseline for vascular disease risk.

“The CVProfilor^® MD-3000 System provides physicians with a better way to identify those patients at risk for cardiovascular disease by providing information that goes beyond the blood pressure cuff,” said Greg H. Guettler, president of Hypertension Diagnostics, Inc. “Cardiovascular disease is the leading cause of death in the European Union and the CVProfilor^® MD-3000 is the first and only vascular disease assessment tool which measures the elasticity of the small arteries – the first to show signs of vascular disease. The CVProfilor^® MD-3000 System provides physicians with a new diagnostic tool with which to take the guesswork out of cardiovascular disease assessment, to manage both hypertensive and diabetic patients and to optimize the elasticity-enhancing properties of cardiovascular drug therapy. No other product in the world can provide this degree of sensitivity,” added Guettler.

Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company’s 2001 Annual Report on Form 10-KSB under the caption “Risk Factors,” as well as others not now anticipated.

CVProfilor is a registered trademark of Hypertension Diagnostics, Inc.
  
Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of Hypertension Diagnostics, Inc. All rights reserved.

Investor Relations: Jens Dalsgaard and Tony Altavilla,
Managing Directors
Redwood Consultants, LLC
Mill Valley, CA 94941
415-380-0500

Contact: Greg H. Guettler, President